Latest Articles about XNPT

XenoPort Resumes Horizant Supply - Analyst Blog

Zacks Equity Research — Thu, 23 May 2013 01:27:19 Z

XenoPort Inc. ( XNPT ) recently commenced shipments of Horizant extended-release tablets in the US. The drug is approved in the US for the treatment of moderate-to-severe primary restless

Bearish MACD for XenoPort, Inc. - Tale of the Tape

Zacks Equity Research — Mon, 22 Apr 2013 20:15:55 Z

XenoPort, Inc. 's ( XNPT ) MACD indicator has moved into bearish territory with a reading of -0.0803. The Zacks Rank #4 ("Sell") stock decreased more than 5.17% to $7.15 in

Bearish MACD for XenoPort, Inc. - Tale of the Tape

Zacks Equity Research — Thu, 28 Mar 2013 19:27:52 Z

XenoPort, Inc. 's ( XNPT ) MACD indicator has moved into bearish territory with a reading of -0.2642. The Zacks Rank #4 ("Sell") stock decreased more than 1.54% to $7.12 in

XenoPort Launches Regnite in Japan - Analyst Blog

Zacks Equity Research — Fri, 13 Jul 2012 03:30:01 Z

XenoPort, Inc. ( XNPT ) and Astellas Pharma Inc. recently announced the launch of Regnite extended-release tablets in Japan for the treatment of moderate-to-severe primary restless legs

Label Expanded for Glaxo/XNPT Drug - Analyst Blog

Zacks Equity Research — Tue, 12 Jun 2012 22:51:42 Z

GlaxoSmithKline plc ( GSK ) and XenoPort, Inc. ( XNPT ) recently announced that their drug, Horizant, has been approved by the US Food and Drug Administration (FDA) for the management of

Quest for Alpha: Micro-Cap Stocks With Big Hedge Fund Buying

Kapitall — Tue, 22 Nov 2011 07:25:02 Z

( Written by Rebecca Lipman. List compiled by Eben Esterhuizen, CFA ) From 1980 to 2007 the share of US common equity held by institutions more than doubled – from 32% to 68% of total market

10 Biotech Stocks Trading at Deep Discounts to Analyst Target Prices

Kapitall — Tue, 01 Nov 2011 05:18:31 Z

(Written by Alexander Crawford. Target price data sourced from Thomson/First Call (via Yahoo! Finance)) Biotech companies deal with many uncertainties, and that directly translates to

Wednesday Losers: Delta Petroleum, FTI Consulting, Xenoport

David Sterman — Wed, 07 Jul 2010 19:42:44 Z

Among the biggest losers in Wedneday's early trading are Delta Petroleum (Nasdaq: DPTR ) , FTI Consulting (NYSE: FCN ) and Xenoport (Nasdaq: XNPT ) .